The burden of cholera

Critical Reviews in Microbiology

Volumn 37, Issue 4, 2011, Pages 337-348

  Murugaiah, Chandrika ^a  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

Author keywords

Antibiotic resistance; Cholera; Dehydration; Diarrhea; Discovery; Ecology; Emerging; Epidemiology; Etiology; Genome structure; Infectious disease; Microbiology; Pandemic; Pathophysiology; Toxins

Indexed keywords

BACTERIAL DNA; BACTERIAL ENZYME; CHITINASE; CHOLERA TOXIN; CHOLERA VACCINE; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; LOMEFLOXACIN; NORFLOXACIN; ORAL REHYDRATION SOLUTION; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RTXA PROTEIN; SPACER DNA; TETRACYCLINE; UNCLASSIFIED DRUG;

ACIDOSIS; AFRICA; ALGAL BLOOM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; AQUACULTURE; AQUATIC ENVIRONMENT; ASIA; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIOPHAGE; BACTERIUM ADHERENCE; BACTERIUM CULTURE; BACTERIUM PILUS; BANGLADESH; BASE PAIRING; BIOTYPE; BLOOD GROUP; BLOOD GROUP AB; BLOOD GROUP B; BLOOD GROUP O; CEREAL; CHOLERA; CHROMOSOME 1; CHROMOSOME 2; CHROMOSOME STRUCTURE; CLIMATE CHANGE; CLINICAL CLASSIFICATION; COASTAL WATERS; COMMENSAL; COPEPOD; DIARRHEA; DISEASE CARRIER; DISEASE PREDISPOSITION; EL NINO; ELECTROLYTE DISTURBANCE; ENVIRONMENTAL CHANGE; ENVIRONMENTAL SANITATION; ESTUARY; FECES CULTURE; FOOD CONTAMINATION; FOOD POISONING; GASTROENTERITIS; GEOGRAPHIC DISTRIBUTION; HORIZONTAL GENE TRANSFER; HUMAN; HYPOVOLEMIC SHOCK; IMMUNE DEFICIENCY; INDIA; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; LOWEST INCOME GROUP; MALNUTRITION; MORTALITY; NATURAL DISASTER; NAUSEA AND VOMITING; OPEN READING FRAME; ORAL REHYDRATION THERAPY; PANDEMIC; PATHOGENESIS; PATHOPHYSIOLOGY; PERSONAL HYGIENE; POLITICS; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RAW FOOD; REPLICON; REVIEW; RICE; SEA SURFACE TEMPERATURE; SEASONAL VARIATION; SEDIMENT; SEWAGE DISPOSAL; STOMACH PH; STRAIN IDENTIFICATION; TROPICS; VACCINATION; VIBRIO CHOLERAE; VIET NAM; WAR; WATER CONTAMINATION;

CHOLERA; DEVELOPING COUNTRIES; DISEASE OUTBREAKS; HUMANS; WORLD HEALTH;

EID: 80053634173     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.3109/1040841X.2011.603288     Document Type: Review

References (182)

1. Abou-Gareeb AH. (1961). Measurement of seasonal variations in endemic cholera in West Bengal. Bull World Health Organ, 25, 93-102.
2. Aguirre-Macedo ML, Vidal-Martinez VM, Herrera-Silveira JA, Valdés-Lozano DS, Herrera-Rodríguez M, Olvera-Novoa MA. (2008). Ballast water as a vector of coral pathogens in the Gulf of Mexico: The case of the Cayo Arcas coral reef. Mar Pollut Bull, 56, 1570-1577.
3. Ajzenman C, Bizet MC, Dufraisse MP, Falip E, Fournier JM, Etchegorry MG, Haeghebaert S, Isnard H, Le Loc'h H, Mansir T, Quilici ML, Raqbi F, Raud E, Roberto Y, Scanvic A, Senellier M, Sirot S, Tarantola A; Groupes de Gestion des Incidents. (2006). Cases of imported cholera in France, summer 2005. A. Tarantola for the incident management teams. Med Mal Infect, 36, 346-348.
4. Alam AN, Gof PA, Abdal NM, Rashid MA, Rahaman MM. (1991). Serum ferritin and cholera. A prospective study. Trop Geogr Med, 43, 12-16.
5. Alam M, Hasan NA, Sadique A, Bhuiyan NA, Ahmed KU, Nusrin S, Nair GB, Siddique AK, Sack RB, Sack DA, Huq A, Colwell RR. (2006). Seasonal cholera caused by Vibrio cholerae serogroups O1 and O139 in the coastal aquatic environment of Bangladesh. Appl Environ Microbiol, 72, 4096-4104. (Pubitemid 43894875)
6. Albert MJ, Islam D, Nahar S, Qadri F, Falklind S, Weintraub A. (1997). Rapid detection of Vibrio cholerae O139 Bengal from stool specimens by PCR. J Clin Microbiol, 35, 1633-1635. (Pubitemid 27216855)
7. Albert MJ, Siddique AK, Islam MS, Faruque AS, Ansaruzzaman M, Faruque SM, Sack RB. (1993). Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh. Lancet, 341, 704. (Pubitemid 23083298)
8. Anstee DJ. (2010). The relationship between blood groups and disease. Blood, 115, 4635-4643.
9. Arakawa T, Chong DK, Langridge WH. (1998). Efcacy of a food plant-based oral cholera toxin B subunit vaccine. Nat Biotechnol, 16, 292-297. (Pubitemid 28120111)
10. Bentivoglio M, Pacini P. (1995). Filippo Pacini: A determined observer. Brain Res Bull, 38, 161-165.
11. Berche P, Poyart C, Abachin E, Lelievre H, Vandepitte J, Dodin A, Fournier JM. (1994). The novel epidemic strain O139 is closely related to the pandemic strain O1 of Vibrio cholerae. J Infect Dis, 170, 701-704. (Pubitemid 24262279)
12. Bhattacharya SK. (1995). Cholera outbreaks: Role of oral rehydration therapy. J Indian Med Assoc, 93, 237-238.
13. Bhattacharya SK. (2003). An evaluation of current cholera treatment. Expert Opin Pharmacother, 4, 141-146. (Pubitemid 36240453)
14. Boardman BK, Meehan BM, Fullner Satchell KJ. (2007). Growth phase regulation of Vibrio cholerae RTX toxin export. J Bacteriol, 189, 1827-1835. (Pubitemid 46446145)
15. Boardman BK, Satchell KJ. (2004). Vibrio cholerae strains with mutations in an atypical type I secretion system accumulate RTX toxin intracellularly. J Bacteriol, 186, 8137-8143. (Pubitemid 39552526)
16. Booth BA, Boesman-Finkelstein M, Finkelstein RA. (1983). Vibrio cholerae soluble hemagglutinin/protease is a metalloenzyme. Infect Immun, 42, 639-644. (Pubitemid 14230259)
17. Booth BA, Boesman-Finkelstein M, Finkelstein RA. (1984). Vibrio cholerae hemagglutinin/protease nicks cholera enterotoxin. Infect Immun, 45, 558-560. (Pubitemid 14066164)
18. Borroto RJ. (1997). Ecology of Vibrio cholerae serogroup 01 in aquatic environments. Rev Panam Salud Publica, 1, 3-8.
19. Boutin JP, Pages F, Migliani R, Chaignat CL, Ivanof B. (2001). Cholera update at the dawn of the millenium. Med Trop (Mars), 61, 513-520.
20. Buechner JS, Constantine H, Gjelsvik A. (2004). John Snow and the Broad Street pump: 150 years of epidemiology. Med Health R I, 87, 314-315.
21. Cairncross S. (1997). More water: Better health. People Planet, 6, 10-11.
22. Cameron D, Jones IG. (1983). John Snow, the broad street pump and modern epidemiology. Int J Epidemiol, 12, 393-396.
23. Carpenter CC. (1992). The treatment of cholera: Clinical science at the bedside. J Infect Dis, 166, 2-14.
24. Cash RA, Narasimhan V. (2000). Impediments to global surveillance of infectious diseases: Consequences of open reporting in a global economy. Bull World Health Organ, 78, 1358-1367.
25. Chaignat CL, Monti V. (2007). Use of oral cholera vaccine in complex emergencies: What next? Summary report of an expert meeting and recommendations of WHO. J Health Popul Nutr, 25, 244-261. (Pubitemid 47610305)
26. Chaignat CL, Monti V, Soepardi J, Petersen G, Sorensen E, Narain J, Kieny MP. (2008). Cholera in disasters: Do vaccines prompt new hopes? Expert Rev Vaccines, 7, 431-435. (Pubitemid 351656814)
27. Chandrasekhar MR, Krishna BV, Patil AB. (2008). Changing characteristics of Vibrio cholerae: Emergence of multidrug resistance and non-O1, non-O139 serogroups. Southeast Asian J Trop Med Public Health, 39, 1092-1097.
28. Chatterjee SN, Chaudhuri K. (2003). Lipopolysaccharides of Vibrio cholerae. I. Physical and chemical characterization. Biochim Biophys Acta, 1639, 65-79. (Pubitemid 38366210)
29. Childers BM, Klose KE. (2007). Regulation of virulence in Vibrio cholerae: The ToxR regulon. Future Microbiol, 2, 335-344. (Pubitemid 47180929)
30. Chomvarin C, Jumroenjit W, Chaicumpar K, Namwat W. (2008). Association of ompU gene in Vibrio cholerae from patients and environment with bile resistance. Southeast Asian J Trop Med Public Health, 39, 876-881.
31. Chowdhury MI, Sheikh A, Qadri F. (2009). Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009. Expert Rev Vaccines, 8, 1643-1652.
32. Ciufecu C, Nacescu N. (1974). Period of survival of some intestinal bacteria in the Cary and Blair preservation and transport medium. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol, 19, 331-338.
33. Colwell RR. (1996). Global climate and infectious disease: The cholera paradigm. Science, 274, 2025-2031. (Pubitemid 27020684)
34. Colwell RR, Huq A. (1994). Environmental reservoir of Vibrio cholerae. The causative agent of cholera. Ann N Y Acad Sci, 740, 44-54.
35. Colwell RR, Huq A, Islam MS, Aziz KM, Yunus M, Khan NH, Mahmud A, Sack RB, Nair GB, Chakraborty J, Sack DA, Russek-Cohen E. (2003). Reduction of cholera in Bangladeshi villages by simple fltration. Proc Natl Acad Sci USA, 100, 1051-1055. (Pubitemid 36183953)
36. Constantin De Magny G, Colwell RR. (2009). Cholera and climate: A demonstrated relationship. Trans Am Clin Climatol Assoc, 120, 119-28.
37. Dajer T. (1992). The deadliest wake-up call. Cholera. Links, 9, 7, 25.
38. Davis BM, Waldor MK. (2003). Filamentous phages linked to virulence of Vibrio cholerae. Curr Opin Microbiol, 6, 35-42. (Pubitemid 36258534)
39. De Haan L, Hirst TR. (2004). Cholera toxin: A paradigm for multifunctional engagement of cellular mechanisms (Review). Mol Membr Biol, 21, 77-92. (Pubitemid 38524366)
40. Deen JL, von Seidlein L, Sur D, Agtini M, Lucas ME, Lopez AL, Kim DR, Ali M, Clemens JD. (2008). The high burden of cholera in children: Comparison of incidence from endemic areas in Asia and Africa. PLoS Negl Trop Dis, 2, e173.
41. Desenclos JC. (1996). Epidemiology of toxic and infectious risk related to shellfsh consumption. Rev Epidemiol Sante Publique, 44, 437-454. (Pubitemid 26354030)
42. DiRita VJ, Parsot C, Jander G, Mekalanos JJ. (1991). Regulatory cascade controls virulence in Vibrio cholerae. Proc Natl Acad Sci USA, 88, 5403-5407. (Pubitemid 21914753)
43. Dutt AK, Alwi S, Velauthan T. (1971). A shellfsh-borne cholera outbreak in Malaysia. Trans R Soc Trop Med Hyg, 65, 815-818.
44. Eberhart-Phillips J, Besser RE, Tormey MP, Koo D, Feikin D, Araneta MR, Wells J, Kilman L, Rutherford GW, Grifn PM, Baron R, Mascola L. (1996). An outbreak of cholera from food served on an international aircraft. Epidemiol Infect, 116, 9-13. (Pubitemid 26112435)
45. Ekra KD, Attoh-Touré H, Bénié BV, Coulibaly D, Koutouan MG, Aka LN, Dagnan SN, Coulibaly A, Douba A, Tiembré I, Odéhouri-Koudou P, Tagliante-Saracino J. (2009). Five years of cholera surveillance in Ivory Coast during social and political crisis, 2001 to 2005. Bull Soc Pathol Exot, 102, 107-109.
46. Epstein PR. (1993). Algal blooms in the spread and persistence of cholera. BioSystems, 31, 209-221. (Pubitemid 24045870)
47. Estrada-García T, Mintz ED. (1996). Cholera: Foodborne transmission and its prevention. Eur J Epidemiol, 12, 461-469. (Pubitemid 26330131)
48. Falade AG, Lawoyin T. (1999). Features of the 1996 cholera epidemic among Nigerian children in Ibadan, Nigeria. J Trop Pediatr, 45, 59-62. (Pubitemid 29094924)
49. Faruque SM, Albert MJ, Mekalanos JJ. (1998). Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae. Microbiol Mol Biol Rev, 62, 1301-1314. (Pubitemid 28558300)
50. Faruque SM, Islam MJ, Ahmad QS, Biswas K, Faruque AS, Nair GB, Sack RB, Sack DA, Mekalanos JJ. (2006). An improved technique for isolation of environmental Vibrio cholerae with epidemic potential: Monitoring the emergence of a multiple-antibiotic-resistant epidemic strain in Bangladesh. J Infect Dis, 193, 1029-1036.
51. Faruque SM, Islam MJ, Ahmad QS, Faruque AS, Sack DA, Nair GB, Mekalanos JJ. (2005a). Self-limiting nature of seasonal cholera epidemics: Role of host-mediated amplifcation of phage. Proc Natl Acad Sci USA, 102, 6119-6124. (Pubitemid 40594265)
52. Faruque SM, Naser IB, Islam MJ, Faruque AS, Ghosh AN, Nair GB, Sack DA, Mekalanos JJ. (2005b). Seasonal epidemics of cholera inversely correlate with the prevalence of environmental cholera phages. Proc Natl Acad Sci USA, 102, 1702-1707. (Pubitemid 40209231)
53. Faruque SM, Tam VC, Chowdhury N, Diraphat P, Dziejman M, Heidelberg JF, Clemens JD, Mekalanos JJ, Nair GB. (2007). Genomic analysis of the Mozambique strain of Vibrio cholerae O1 reveals the origin of El Tor strains carrying classical CTX prophage. Proc Natl Acad Sci USA, 104, 5151-5156. (Pubitemid 47186191)
54. Fasano A, Baudry B, Pumplin DW, Wasserman SS, Tall BD, Ketley JM, Kaper JB. (1991). Vibrio cholerae produces a second enterotoxin, which afects intestinal tight junctions. Proc Natl Acad Sci USA, 88, 5242-5246. (Pubitemid 21914720)
55. Favre D, Struck MM, Cryz SJ Jr, Viret JF. (1996). Further molecular characterization and stability of the live oral attenuated cholera vaccine strain CVD103-HgR. Vaccine, 14, 526-531. (Pubitemid 26173754)
56. Finkelstein RA, Boesman-Finkelstein M, Chang Y, Häse CC. (1992). Vibrio cholerae hemagglutinin/protease, colonial variation, virulence, and detachment. Infect Immun, 60, 472-478.
57. Finkelstein RA, Boesman-Finkelstein M, Holt P. (1983). Vibrio cholerae hemagglutinin/lectin/protease hydrolyzes fbronectin and ovomucin: F.M. Burnet revisited. Proc Natl Acad Sci USA, 80, 1092-1095. (Pubitemid 13118092)
58. Finkelstein RA, Hanne L F. (1982). Purifcation and characterization of the soluble hemagglutinin (cholera lectin)(produced by Vibrio cholerae. Infect Immun, 36, 1199-1208. (Pubitemid 12124841)
59. Fontana MR, Monaci E, Yanqing L, Guoming Q, Duan G, Rappuoli R, Pizza M. (2000). IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxifed derivatives of cholera toxin. Vaccine, 19, 75-85. (Pubitemid 30618957)
60. Fournier JM, Quilici ML. (2007). Cholera. Presse Med, 36, 727-739.
61. Fullner KJ, Lencer WI, Mekalanos JJ. (2001). Vibrio cholerae-induced cellular responses of polarized T84 intestinal epithelial cells are dependent on production of cholera toxin and the RTX toxin. Infect Immun, 69, 6310-6317. (Pubitemid 32885196)
62. Fullner KJ, Mekalanos JJ. (2000). In vivo covalent cross-linking of cellular actin by the Vibrio cholerae RTX toxin. EMBO J, 19, 5315-5323.
63. Gabastou JM, Pesantes C, Escalante S, Narváez Y, Vela E, García L, Zabala D, Yadon ZE. (2002). Characteristics of the cholera epidemic of 1998 in Ecuador during El Niño. Rev Panam Salud Publica, 12, 157-164.
64. Gallardo AA, Risso S, Fajardo MA, Estevao Belchior S. (2004). Characterization of microbial population present in the edible seaweed, Monostroma undulatum, Wittrock. Arch Latinoam Nutr, 54, 337-345. (Pubitemid 40470170)
65. Ganin VS. (2009). Cholera and war. Voen Med Zh, 330, 83-88.
66. Ghose AC. (1996). Adherence & colonization properties of Vibrio cholerae & diarrhoeagenic Escherichia coli. Indian J Med Res, 104, 38-51. (Pubitemid 26254158)
67. Giono-Cerezo S, Zárate A, Gutiérrez L, Valdespino JL. (1994). Antibiotic resistance pattern of 24, 526 strains of Vibrio cholerae O1 isolated in Mexico from 1991 to 1993. Rev Latinoam Microbiol, 36, 257-262.
68. Glass RI, Holmgren J, Haley CE, Khan MR, Svennerholm AM, Stoll BJ, Belayet Hossain KM, Black RE, Yunus M, Barua D. (1985). Predisposition for cholera of individuals with O blood group. Possible evolutionary signifcance. Am J Epidemiol, 121, 791-796. (Pubitemid 15028255)
69. Goh KT, Lam S. (1981). Vibrio infections in Singapore. Ann Acad Med Singap, 10, 2-10. (Pubitemid 11005635)
70. Gopal S, Otta SK, Kumar S, Karunasagar I, Nishibuchi M, Karunasagar I. (2005). The occurrence of Vibrio species in tropical shrimp culture environments; implications for food safety. Int J Food Microbiol, 102, 151-159. (Pubitemid 40898120)
71. Gorbach SL, Banwell JG, Jacobs B, Chatterjee BD, Mitra R, Brigham KL, Neogy KN. (1970). Intestinal microfora in Asiatic cholera. I. "Rice-water" stool. J Infect Dis, 121, 32-37.
72. Grifth DC, Kelly-Hope LA, Miller MA. (2006). Review of reported cholera outbreaks worldwide, 1995-2005. Am J Trop Med Hyg, 75, 973-977. (Pubitemid 351627552)
73. Grujic D, Moric O, Zonjic S, Canic M, Djordjevic S, Petrovic T, Pavlovic D, Zivic-Aleksic J, Milosavljevic R, Tasic G. (1991). Laboratory diagnosis of cholera during enterocolitis epidemic at Dimitrovgrad in August and September 1989. Srp Arh Celok Lek, 119, 310-313.
74. Hare R. (1955). John Snow and the cholera epidemic of 1854. Med World, 82, 183-195.
75. Häse CC, Finkelstein RA. (1991). Cloning and nucleotide sequence of the Vibrio cholerae hemagglutinin/protease (HA/protease) gene and construction of an HA/protease-negative strain. J Bacteriol, 173, 3311-3317.
76. Heidelberg JF, Eisen JA, Nelson WC, Clayton RA, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Umayam L, Gill SR, Nelson KE, Read TD, Tettelin H, Richardson D, Ermolaeva MD, Vamathevan J, Bass S, Qin H, Dragoi I, Sellers P, McDonald L, Utterback T, Fleishmann RD, Nierman WC, White O, Salzberg SL, Smith HO, Colwell RR, Mekalanos JJ, Venter JC, Fraser CM. (2000). DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature, 406, 477-483. (Pubitemid 30625724)
77. Hervio-Heath D, Colwell RR, Derrien A, Robert-Pillot A, Fournier JM, Pommepuy M. (2002). Occurrence of pathogenic vibrios in coastal areas of France. J Appl Microbiol, 92, 1123-1135. (Pubitemid 34535493)
78. Hill DR. (1992). Immunizations for foreign travel. Yale J Biol Med, 65, 293-315. (Pubitemid 23023395)
79. Huber KE, Waldor MK. (2002). Filamentous phage integration requires the host recombinases XerC and XerD. Nature, 417, 656-659. (Pubitemid 34614825)
80. Huo A, Xu B, Chowdhury MA, Islam MS, Montilla R, Colwell RR. (1996). A simple fltration method to remove plankton-associated Vibrio cholerae in raw water supplies in developing countries. Appl Environ Microbiol, 62, 2508-2512. (Pubitemid 26231223)
81. Huq A, Small EB, West PA, Huq MI, Rahman R, Colwell RR. (1983). Ecological relationships between Vibrio cholerae and planktonic crustacean copepods. Appl Environ Microbiol, 45, 275-283. (Pubitemid 13175306)
82. Huq A, Yunus M, Sohel SS, Bhuiya A, Emch M, Luby SP, Russek-Cohen E, Nair GB, Sack RB, Colwell RR. (2010). Simple sari cloth fltration of water is sustainable and continues to protect villagers from cholera in Matlab, Bangladesh. MBio, 1.
83. Islam MS, Sharker MA, Rheman S, Hossain S, Mahmud ZH, Islam MS, Uddin AM, Yunus M, Osman MS, Ernst R, Rector I, Larson CP, Luby SP, Endtz HP, Cravioto A. (2009). Efects of local climate variability on transmission dynamics of cholera in Matlab, Bangladesh. Trans R Soc Trop Med Hyg, 103, 1165-1170.
84. Jensen MA, Faruque SM, Mekalanos JJ, Levin BR. (2006). Modeling the role of bacteriophage in the control of cholera outbreaks. Proc Natl Acad Sci USA, 103, 4652-4657.
85. Jiang SC, Matte M, Matte G, Huq A, Colwell RR. (2000). Genetic diversity of clinical and environmental isolates of Vibrio cholerae determined by amplifed fragment length polymorphism fngerprinting. Appl Environ Microbiol, 66, 148-153. (Pubitemid 30030509)
86. Johnson JA, Morris JG Jr, Kaper JB. (1993). Gene encoding zonula occludens toxin (zot) does not occur independently from cholera enterotoxin genes (ctx) in Vibrio cholerae. J Clin Microbiol, 31, 732-733. (Pubitemid 23059904)
87. Kaper JB, Morris JG Jr, Levine MM. (1995). Cholera. Clin Microbiol Rev, 8, 48-86.
88. Kaper JB, Srivastava BS. (1992). Genetics of cholera toxin. Indian J Med Res, 95, 163-167. (Pubitemid 23032968)
89. Karki R, Bhatta DR, Malla S, Dumre SP. (2010). Cholera incidence among patients with diarrhea visiting National Public Health Laboratory, Nepal. Jpn J Infect Dis, 63, 185-187.
90. Keen MF, Bujalski L. (1992). The diagnosis and treatment of cholera. Nurse Pract, 17, 53-56.
91. Khan MU, Shahidullah M, Barua DK, Begum T. (1986). Epidemiological diferences between cholera due to multiple antibiotic resistant and multiple antibiotic sensitive Vibrio cholerae infection. Trans R Soc Trop Med Hyg, 80, 60-63. (Pubitemid 17217222)
92. Khan MU, Shahidullah MD, Haque MS, Ahmed WU. (1984). Presence of vibrios in surface water and their relation with cholera in a community. Trop Geogr Med, 36, 335-340. (Pubitemid 15159116)
93. Khin Maung U, Greenough WB, 3rd. (1991). Cereal-based oral rehydration therapy. I. Clinical studies. J Pediatr, 118, S72-9.
94. Kimsey HH, Waldor MK. (1998). Vibrio cholerae hemagglutinin/protease inactivates CTXphi. Infect Immun, 66, 4025-4029. (Pubitemid 28402666)
95. Kimsey HH, Waldor MK. (2004). The CTXphi repressor RstR binds DNA cooperatively to form tetrameric repressor-operator complexes. J Biol Chem, 279, 2640-2647. (Pubitemid 38114251)
96. King AA, Ionides EL, Pascual M, Bouma MJ. (2008). Inapparent infections and cholera dynamics. Nature, 454, 877-880.
97. Kirigia JM, Sambo LG, Yokouide A, Soumbey-Alley E, Muthuri LK, Kirigia DG. (2009). Economic burden of cholera in the WHO African region. BMC Int Health Hum Rights, 9, 8.
98. Koelle K. (2009). The impact of climate on the disease dynamics of cholera. Clin Microbiol Infect, 15 Suppl 1, 29-31.
99. Koelle K, Rodó X, Pascual M, Yunus M, Mostafa G. (2005). Refractory periods and climate forcing in cholera dynamics. Nature, 436, 696-700. (Pubitemid 41117271)
100. Kossaczka Z, Shiloach J, Johnson V, Taylor DN, Finkelstein RA, Robbins JB, Szu SC. (2000). Vibrio cholerae O139 conjugate vaccines: Synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice. Infect Immun, 68, 5037-5043.
101. Kruse H, Sørum H, Tenover FC, Olsvik O. (1995). A transferable multiple drug resistance plasmid from Vibrio cholerae O1. Microb Drug Resist, 1, 203-210.
102. Lee JH, Kim MW, Kim BS, Kim SM, Lee BC, Kim TS, Choi SH. (2007). Identifcation and characterization of the Vibrio vulnifcus rtxA essential for cytotoxicity in vitro and virulence in mice. J Microbiol, 45, 146-152.
103. Lesmana M, Rockhill RC, Sutanti D, Sutomo A. (1985). An evaluation of alkaline peptone water for enrichment of Vibrio cholerae in feces. Southeast Asian J Trop Med Public Health, 16, 265-267. (Pubitemid 16226888)
104. Lin W, Fullner KJ, Clayton R, Sexton JA, Rogers MB, Calia KE, Calderwood SB, Fraser C, Mekalanos JJ. (1999). Identifcation of a Vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage. Proc Natl Acad Sci USA, 96, 1071-1076. (Pubitemid 29072185)
105. Lipp EK, Huq A, Colwell RR. (2002). Efects of global climate on infectious disease: The cholera model. Clin Microbiol Rev, 15, 757-770. (Pubitemid 41184086)
106. Lobitz B, Beck L, Huq A, Wood B, Fuchs G, Faruque AS, Colwell R. (2000). Climate and infectious disease: Use of remote sensing for detection of Vibrio cholerae by indirect measurement. Proc Natl Acad Sci USA, 97, 1438-1443. (Pubitemid 30118459)
107. Lopez AL, Clemens JD, Deen J, Jodar L. (2008). Cholera vaccines for the developing world. Hum Vaccin, 4, 165-169. (Pubitemid 351881187)
108. Mahon BE, Mintz ED, Greene KD, Wells JG, Tauxe RV. (1996). Reported cholera in the United States, 1992-1994: A refection of global changes in cholera epidemiology. JAMA, 276, 307-312. (Pubitemid 26249535)
109. Menzl K, Maier E, Chakraborty T, Benz R. (1996). HlyA hemolysin of Vibrio cholerae O1 biotype E1 Tor. Identifcation of the hemolytic complex and evidence for the formation of anion-selective ion-permeable channels. Eur J Biochem, 240, 646-654. (Pubitemid 26321167)
110. Miller CJ, Feachem RG, Drasar BS. (1985). Cholera epidemiology in developed and developing countries: New thoughts on transmission, seasonality, and control. Lancet, 1, 261-262.
111. Misch A. (1991). Sanitation in the time of cholera. World Watch, 4, 37-38.
112. Mmwr C. (1993). Imported cholera associated with a newly described toxigenic Vibrio cholerae O139 strain-California, 1993. Mmwr Morb Mortal Wkly Rep, 42, 501-503.
113. Molla AM, Sarker SA, Hossain M, Molla A, Greenough WB 3rd. (1982). Rice-powder electrolyte solution as oral-therapy in diarrhoea due to Vibrio cholerae and Escherichia coli. Lancet, 1, 1317-1319. (Pubitemid 12119214)
114. Morris JG Jr.(2003). Cholera and other types of vibriosis: A story of human pandemics and oysters on the half shell. Clin Infect Dis, 37, 272-280. (Pubitemid 36930358)
115. Nair GB, Ramamurthy T, Bhattacharya SK, Mukhopadhyay AK, Garg S, Bhattacharya MK, Takeda T, Shimada T, Takeda Y, Deb BC. (1994a). Spread of Vibrio cholerae O139 Bengal in India. J Infect Dis, 169, 1029-1034. (Pubitemid 24303222)
116. Nair GB, Shimada T, Kurazono H, Okuda J, Pal A, Karasawa T, Mihara T, Uesaka Y, Shirai H, Garg S. (1994b). Characterization of phenotypic, serological, and toxigenic traits of Vibrio cholerae O139 bengal. J Clin Microbiol, 32, 2775-2779. (Pubitemid 24319118)
117. Nalin DR. (1976). Cholera, copepods, and chitinase. Lancet, 2, 958.
118. Nalin DR. (2009). Oral rehydration for cholera. Clin Infect Dis, 48, 839-40; author reply 840.
119. Nathavitharana KA, Booth IW. (1992). Pharmacoeconomics of the therapy of diarrhoeal disease. Pharmacoeconomics, 2, 305-323.
120. Nettleman MD. (1991). Cholera, travel, and infection control. Infect Control Hosp Epidemiol, 12, 558-562.
121. Oeding P. (1990). Cholera in Drammen 1832-the frst time in Norway. Tidsskr Nor Laegeforen, 110, 3854-3859.
122. Pascual M, Bouma MJ, Dobson AP. (2002). Cholera and climate: Revisiting the quantitative evidence. Microbes Infect, 4, 237-245. (Pubitemid 34183499)
123. Paz S. (2009). Impact of temperature variability on cholera incidence in southeastern Africa, 1971-2006. Ecohealth, 6, 340-345.
124. Pearson GD, Woods A, Chiang SL, Mekalanos JJ. (1993). CTX genetic element encodes a site-specifc recombination system and an intestinal colonization factor. Proc Natl Acad Sci USA, 90, 3750-3754. (Pubitemid 23111445)
125. Phillips RA. (1964). WATER AND ELECTROLYTE LOSSES IN CHOLERA. Fed Proc, 23, 705-712.
126. Phillips RA. (1966). Cholera in the perspective of 1966. Ann Intern Med, 65, 922-930.
127. Pillai GV, Brueton MJ, Burston D, Sandhu BK. (1994). Evaluation of the efects of varying solute content on the efcacy of oral rehydration solutions in a rat model of secretory diarrhoea. J Pediatr Gastroenterol Nutr, 18, 457-460. (Pubitemid 24164676)
128. Rabbani GH. (2000). The search for a better oral rehydration solution for cholera. N Engl J Med, 342, 345-347. (Pubitemid 30075250)
129. Rabbani GH, Greenough WB 3rd. (1999). Food as a vehicle of transmission of cholera. J Diarrhoeal Dis Res, 17, 1-9.
130. Radu S, Vincent M, Apun K, Abdul-Rahim R, Benjamin PG, Yuherman, Rusul G. (2002). Molecular characterization of Vibrio cholerae O1 outbreak strains in Miri, Sarawak (Malaysia). Acta Trop, 83, 169-176. (Pubitemid 34671164)
131. Ramamurthy T, Garg S, Sharma R, Bhattacharya SK, Nair GB, Shimada T, Takeda T, Karasawa T, Kurazano H, Pal A. (1993). Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet, 341, 703-704. (Pubitemid 23083297)
132. Ranjbar M, Rahmani E, Nooriamiri A, Gholami H, Golmohamadi A, Barati H, Rajabifar D, Barati S, Sabet MS, Zamiri A, Haghighi S, Taifehashemi P, Nojomi M. (2010). High prevalence of multidrug-resistant strains of Vibrio cholerae, in a cholera outbreak in Tehran-Iran, during June-September 2008. Trop Doct, 40, 214-216.
133. Reidl J, Klose KE. (2002). Vibrio cholerae and cholera: Out of the water and into the host. FEMS Microbiol Rev, 26, 125-139. (Pubitemid 34634084)
134. Robert A, Silva A, Benitez JA, Rodriguez BL, Fando R, Campos J, Sengupta DK, Boesman-Finkelstein M, Finkelstein RA. (1996). Tagging a Vibrio cholerae El Tor candidate vaccine strain by disruption of its hemagglutinin/protease gene using a novel reporter enzyme: Clostridium thermocellum endoglucanase A. Vaccine, 14, 1517-1522. (Pubitemid 27023495)
135. Roychowdhury A, Pan A, Dutta D, Mukhopadhyay AK, Ramamurthy T, Nandy RK, Bhattacharya SK, Bhattacharya MK. (2008). Emergence of tetracycline-resistant Vibrio cholerae O1 serotype Inaba, in Kolkata, India. Jpn J Infect Dis, 61, 128-129. (Pubitemid 351663806)
136. Sack DA, Sack RB, Nair GB, Siddique AK. (2004). Cholera. Lancet, 363, 223-233. (Pubitemid 38114723)
137. Sack RB, Albert MJ, Siddique AK. (1996). Emergence of Vibrio cholerae O139. Curr Clin Top Infect Dis, 16, 172-193.
138. Sánchez J, Holmgren J. (2005). Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea. Curr Opin Immunol, 17, 388-398. (Pubitemid 40848541)
139. Sanyal SC. (2000). Cholera in its present day scenario. J Indian Med Assoc, 98, 371-376. (Pubitemid 33644266)
140. Sarah MM., Matthew KW. (2004). Characterization of XerC-and XerD-dependent CTX phage integration in Vibrio cholerae. Molecular Microbiology, 54, 935-947.
141. Satchell KJ. (2007). MARTX, multifunctional autoprocessing repeats-in-toxin toxins. Infect Immun, 75, 5079-5084. (Pubitemid 350033594)
142. Scarpignato C, Rampal P. (1995). Prevention and treatment of traveler's diarrhea: A clinical pharmacological approach. Chemotherapy, 41 Suppl 1, 48-81.
143. Schultz SG. (2007). From a pump handle to oral rehydration therapy: A model of translational research. Adv Physiol Educ, 31, 288-293.
144. Seas C, DuPont HL, Valdez LM, Gotuzzo E. (1996). Practical guidelines for the treatment of cholera. Drugs, 51, 966-973. (Pubitemid 26164166)
145. Seas C, Gotuzzo E. (1996). Cholera: Overview of epidemiologic, therapeutic, and preventive issues learned from recent epidemics. International Journal of Infectious Diseases, 1, 37-46. (Pubitemid 126476605)
146. Seshadri R, Joseph SW, Chopra AK, Sha J, Shaw J, Graf J, Haft D, Wu M, Ren Q, Rosovitz MJ, Madupu R, Tallon L, Kim M, Jin S, Vuong H, Stine OC, Ali A, Horneman AJ, Heidelberg JF. (2006). Genome sequence of Aeromonas hydrophila ATCC 7966T: Jack of all trades. J Bacteriol, 188, 8272-8282. (Pubitemid 44845699)
147. Shears P. (1994). Cholera. Ann Trop Med Parasitol, 88, 109-122. (Pubitemid 24201894)
148. Siddique AK, Akram K, Zaman K, Mutsuddy P, Eusof A, Sack RB. (1996). Vibrio cholerae O139: How great is the threat of a pandemic? Trop Med Int Health, 1, 393-398.
149. Siddique AK, Islam Q, Akram K, Mazumder Y, Mitra A, Eusof A. (1989a). Cholera epidemic and natural disasters; where is the link. Trop Geogr Med, 41, 377-382. (Pubitemid 20286954)
150. Siddique AK, Zaman K, Majumder Y, Islam Q, Bashir I, Mutsuddy P, Eusof A. (1989b). Simultaneous outbreaks of contrasting drug resistant classic and El Tor Vibrio cholerae O1 in Bangladesh. Lancet, 2, 396. (Pubitemid 19189104)
151. Silva AJ, Pham K, Benitez JA. (2003). Haemagglutinin/protease expression and mucin gel penetration in El Tor biotype Vibrio cholerae. Microbiology (Reading, Engl), 149, 1883-1891. (Pubitemid 36874333)
152. Sood S, Das BK, Kapil A, Rattan A. (1996). TCBS for the isolation of Vibrio cholerae. Trop Gastroenterol, 17, 177.
153. Stefen R, Acar J, Walker E, Zuckerman J. (2003). Cholera: Assessing the risk to travellers and identifying methods of protection. Travel Med Infect Dis, 1, 80-88. (Pubitemid 40432881)
154. Talavera A, Año G, García H, Moreira T, Delgado H, Riverón L, Gil S, Miranda A, Cedré B, Valmaseda T, Pino Y, Pérez JL, Infante J F, García L, Sierra G. (2006). Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638. Vaccine, 24, 3746-3749. (Pubitemid 44308219)
155. Talavera A, Pérez EM. (2009). Is cholera disease associated with poverty? J Infect Dev Ctries, 3, 408-411.
156. Tarantola A, Ioos S, Lapidus N. (2005). Current cholera epidemics in west Africa and risks of imported cases in European countries. Euro Surveill, 10, E050901.2.
157. Taylor RK, Kirn TJ, Meeks MD, Wade TK, Wade WF. (2004). A Vibrio cholerae classical TcpA amino acid sequence induces protective antibody that binds an area hypothesized to be important for toxin-coregulated pilus structure. Infect Immun, 72, 6050-6060. (Pubitemid 39303720)
158. Tiagarajah JR, Verkman AS. (2005). New drug targets for cholera therapy. Trends Pharmacol Sci, 26, 172-175. (Pubitemid 40432650)
159. Tiem VD, Deen JL, von Seidlein L, Canh do G, Anh DD, Park JK, Ali M, Danovaro-Holliday MC, Son ND, Hoa NT, Holmgren J, Clemens JD. (2006). Long-term efectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam. Vaccine, 24, 4297-4303.
160. Tomas J, Josserand C, André LJ. (1974). Physiopathology of diarrhea in cholera. Arch Fr Mal App Dig, 63, 327-341.
161. Tompson FL, Iida T, Swings J. (2004). Biodiversity of vibrios. Microbiol Mol Biol Rev, 68, 403-31 (Pubitemid 39238276)
162. Trucksis M, Conn TL, Fasano A, Kaper JB. (1997). Production of Vibrio cholerae accessory cholera enterotoxin (Ace) in the yeast Pichia pastoris. Infect Immun, 65, 4984-4988. (Pubitemid 27513540)
163. Trucksis M, Galen JE, Michalski J, Fasano A, Kaper JB. (1993). Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. Proc Natl Acad Sci USA, 90, 5267-5271. (Pubitemid 23183019)
164. Varela P, Pollevick GD, Rivas M, Chinen I, Binsztein N, Frasch AC, Ugalde RA. (1994). Direct detection of Vibrio cholerae in stool samples. J Clin Microbiol, 32, 1246-1248. (Pubitemid 24132554)
165. Vezzulli L, Pezzati E, Moreno M, Fabiano M, Pane L, Pruzzo C; VibrioSea Consortium. (2009). Benthic ecology of Vibrio spp. and pathogenic Vibrio species in a coastal Mediterranean environment (La Spezia Gulf, Italy). Microb Ecol, 58, 808-818.
166. von Seidlein L. (2007). Vaccines for cholera control: Does herd immunity play a role. PLoS Med, 4, e331.
167. Waldor MK, Mekalanos JJ. (1996). Lysogenic conversion by a flamentous phage encoding cholera toxin. Science, 272, 1910-1914.
168. Weber JT, Mintz ED, Cañizares R, Semiglia A, Gomez I, Sempértegui R, Dávila A, Greene KD, Puhr ND, Cameron DN. (1994). Epidemic cholera in Ecuador: Multidrug-resistance and transmission by water and seafood. Epidemiol Infect, 112, 1-11. (Pubitemid 24048653)
169. WHO. (1979). The control of acute diarrhoeal diseases: WHO and UNICEF collaborate in country programmes. WHO Chron, 33, 131-134.
170. WHO. (1991). Cholera: Ancient scourge on the rise. WHO announces global plan for cholera control. (25 April 1991). WHO Feature, 1-3.
171. WHO. (1993). Cholera and international trade in food. Bull World Health Organ, 71, 120-121
172. WHO. (1995). Cholera in 1994. Part I. Wkly Epidemiol Rec, 70, 201-208.
173. WHO. (1998). El Nino and its impact on health. Epidemiol Bull, 19, 9-13.
174. WHO. (2002). WHO Global Task Force on Cholera Control. Cholera vaccines: A new public health tool. 2002. Meeting report. WHO meeting, 10-11
175. December 2002; Geneva, Switzerland. Report number WHO/CDS/CPE/ZFK/2004.5. WHO. (2005). WHO Global Task Force on Cholera Control. Oral cholera vaccine use in complex emergencies: What next. 2006. Meeting report. WHO Meeting, 14-16.
176. December 2005; Cairo, Egypt. Report number WHO/CDS/NTD/IDM/2006.2. WHO. (2007). Cholera, 2006. Wkly Epidemiol Rec, 82, 273-284.
177. WHO. (2008). Cholera, 2007. Wkly Epidemiol Rec, 83, 269-83.
178. Wu Z, Nybom P, Magnusson KE. (2000). Distinct efects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction-associated proteins occludin and ZO-1. Cell Microbiol, 2, 11-17. (Pubitemid 30225063)
179. Wu Z, Nybom P, Sundqvist T, Magnusson KE. (1998). Endogenous nitric oxide in MDCK-I cells modulates the Vibrio cholerae haemagglutinin/protease (HA/P)-mediated cytotoxicity. Microb Pathog, 24, 321-326. (Pubitemid 28266815)
180. Xu G, Wang S, Zhuang L, Hackett A, Gu L, Zhang L, Zhang C, Wang H, Huang Z, Lu S. (2009). Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera. Vaccine, 27, 3821-3830.
181. Zhang RG, Scott DL, Westbrook ML, Nance S, Spangler BD, Shipley GG, Westbrook EM. (1995). The three-dimensional crystal structure of cholera toxin. J Mol Biol, 251, 563-573.
182. Zo YG, Chokesajjawatee N, Grim C, Arakawa E, Watanabe H, Colwell RR. (2009). Diversity and seasonality of bioluminescent Vibrio cholerae populations in Chesapeake Bay. Appl Environ Microbiol, 75, 135-146.